Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Did you take more than 400 MG of Bextra a day?

Have any of the following side effects occurred? (Please check all that apply.)

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

FDA Warns of Heart Risk For Pfizer's Bextra

Dec 9, 2004 | AFX The U.S. Food and Drug Administration said on Thursday that Pfizer's new pain drug Bextra will carry a labeled warning about a risk of cardiac and blood-clotting.

However, the agency said that, based on what it knows now, the therapy's benefits still appear to outweigh its risks when used properly.

Pfizer's drug is approved to treat the symptoms of osteoarthritis and rheumatoid arthritis, and menstrual pain.

Last month, study results presented at an American Heart Association meeting in New Orleans showed that patients taking Bextra had double the risk of heart attack and stroke compared with those taking placebo.

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo